1. Home
  2. LTRN vs NTWK Comparison

LTRN vs NTWK Comparison

Compare LTRN & NTWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LTRN
  • NTWK
  • Stock Information
  • Founded
  • LTRN 2013
  • NTWK 1997
  • Country
  • LTRN United States
  • NTWK United States
  • Employees
  • LTRN N/A
  • NTWK N/A
  • Industry
  • LTRN Biotechnology: Pharmaceutical Preparations
  • NTWK Computer Software: Prepackaged Software
  • Sector
  • LTRN Health Care
  • NTWK Technology
  • Exchange
  • LTRN Nasdaq
  • NTWK Nasdaq
  • Market Cap
  • LTRN 46.7M
  • NTWK N/A
  • IPO Year
  • LTRN 2020
  • NTWK 1998
  • Fundamental
  • Price
  • LTRN $3.74
  • NTWK $2.35
  • Analyst Decision
  • LTRN Hold
  • NTWK
  • Analyst Count
  • LTRN 1
  • NTWK 0
  • Target Price
  • LTRN N/A
  • NTWK N/A
  • AVG Volume (30 Days)
  • LTRN 47.1K
  • NTWK 27.2K
  • Earning Date
  • LTRN 05-08-2025
  • NTWK 05-08-2025
  • Dividend Yield
  • LTRN N/A
  • NTWK N/A
  • EPS Growth
  • LTRN N/A
  • NTWK N/A
  • EPS
  • LTRN N/A
  • NTWK N/A
  • Revenue
  • LTRN N/A
  • NTWK $62,048,128.00
  • Revenue This Year
  • LTRN N/A
  • NTWK N/A
  • Revenue Next Year
  • LTRN N/A
  • NTWK N/A
  • P/E Ratio
  • LTRN N/A
  • NTWK N/A
  • Revenue Growth
  • LTRN N/A
  • NTWK 9.28
  • 52 Week Low
  • LTRN $2.79
  • NTWK $2.28
  • 52 Week High
  • LTRN $11.99
  • NTWK $3.34
  • Technical
  • Relative Strength Index (RSI)
  • LTRN 42.37
  • NTWK 33.97
  • Support Level
  • LTRN $3.40
  • NTWK $2.33
  • Resistance Level
  • LTRN $4.00
  • NTWK $2.54
  • Average True Range (ATR)
  • LTRN 0.33
  • NTWK 0.11
  • MACD
  • LTRN -0.04
  • NTWK -0.01
  • Stochastic Oscillator
  • LTRN 32.11
  • NTWK 9.09

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.

Share on Social Networks: